ENTPD1 and neoplasm: In a tumour-immune context, CD39 expression on activated CD4+ T-cells is indicative of exhausted T-cells that carry out effector functions, where CD39 contributes to T-cell attrition and clonal contraction of CD4+ T-cells [64].